Most Read Articles
Rachel Soon, 06 Feb 2017

Similarities in insulin signaling mechanisms between the brains of Alzheimer’s disease patients and the pancreas of diabetic patients may point the way to improved treatment for the former, according to researchers.

08 Sep 2019
High-resistant starch, low-protein flour improves blood glucose and lipid levels among people with early type 2 diabetic neuropathy, as well as improves their ability to prevent antioxidative stress, reports a recent study.

Cognitive decline in schizophrenia, other psychoses varies across neuropsychological functions

02 Aug 2019
Parents who scored well on the executive function tests were more likely to have children with better performance.

Cognitive decline is inevitable in patients with schizophrenia and other psychoses following illness onset, but the degree of this decline fluctuates across cognitive functions, according to a study.

“Distinct mechanisms consequent to the illness and/or psychosocial factors may underlie impairments across different cognitive functions,” the authors said.

Patients with schizophrenia experienced declines in IQ as well as in measures of verbal knowledge and of memory, but not processing speed or executive functions. Impairments in processing speed and executive function had already manifested at the first episode and remained stable afterwards.

The magnitude of decline had a range of 0.28 to 0.66 standard deviations. Declines in measures of memory were not exclusive to the schizophrenia group and were also evident in patients with other psychoses. Furthermore, there was no evidence of decline among healthy individuals with low IQ, which suggests that a decline is specific to psychosis.

This study sought to determine whether schizophrenia patients experienced cognitive decline after the first episode, whether this decline was generalized or confined to individual neuropsychological functions, and whether decline was specific to schizophrenia.

The authors analysed patients with first-episode psychosis from a population-based, case-control study, who were prospectively followed up to 10 years after first admission. They administered a neuropsychological battery to patients with a diagnosis of schizophrenia (n=65) or other psychoses (n=41) and to healthy comparison participants (n=103) at index presentation and at follow-up.

“Schizophrenia is associated with a marked cognitive impairment that is widely believed to remain stable after illness onset,” the authors said. “Yet, to date, 10-year prospective studies of cognitive functioning following the first episode with good methodology are rare.”

Editor's Recommendations
Most Read Articles
Rachel Soon, 06 Feb 2017

Similarities in insulin signaling mechanisms between the brains of Alzheimer’s disease patients and the pancreas of diabetic patients may point the way to improved treatment for the former, according to researchers.

08 Sep 2019
High-resistant starch, low-protein flour improves blood glucose and lipid levels among people with early type 2 diabetic neuropathy, as well as improves their ability to prevent antioxidative stress, reports a recent study.